BR9507643A - Methods of use for peroxynitrite decomposition catalysts pharmaceutical compositions for them - Google Patents

Methods of use for peroxynitrite decomposition catalysts pharmaceutical compositions for them

Info

Publication number: BR9507643A
Authority: BR; Brazil
Prior art keywords: methods; pharmaceutical compositions; decomposition catalysts; peroxynitrite decomposition; peroxynitrite
Prior art date: 1994-05-13

Application number

BR9507643A

Other languages

Portuguese (pt)

Inventor

Michael Keith Stern

Daniela Salvemini

Original Assignee

Monsanto Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-05-13

Filing date

1995-05-09

Publication date

1997-09-23

1995-05-09 Application filed by Monsanto Co filed Critical Monsanto Co

1997-09-23 Publication of BR9507643A publication Critical patent/BR9507643A/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/295—Iron group metal compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Biomedical Technology (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Oncology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Communicable Diseases (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Catalysts (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

BR9507643A 1994-05-13 1995-05-09 Methods of use for peroxynitrite decomposition catalysts pharmaceutical compositions for them BR9507643A (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US24249894A	1994-05-13	1994-05-13
PCT/US1995/005886 WO1995031197A1 (en)	1994-05-13	1995-05-09	Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor

Publications (1)

Publication Number	Publication Date
BR9507643A true BR9507643A (en)	1997-09-23

Family

ID=22915009

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BR9507643A BR9507643A (en)	1994-05-13	1995-05-09	Methods of use for peroxynitrite decomposition catalysts pharmaceutical compositions for them

Country Status (13)

Country	Link
EP (1)	EP0758892A1 (en)
JP (1)	JPH10500671A (en)
CN (1)	CN1222286C (en)
AU (1)	AU709553B2 (en)
BR (1)	BR9507643A (en)
CA (1)	CA2189528A1 (en)
CZ (1)	CZ323496A3 (en)
FI (1)	FI964537A7 (en)
HU (1)	HUT76327A (en)
NO (1)	NO964793L (en)
NZ (1)	NZ285648A (en)
PL (1)	PL317192A1 (en)
WO (1)	WO1995031197A1 (en)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6127356A (en)	1993-10-15	2000-10-03	Duke University	Oxidant scavengers
US5994339A (en) *	1993-10-15	1999-11-30	University Of Alabama At Birmingham Research Foundation	Oxidant scavengers
WO1996009053A1 (en) *	1994-09-20	1996-03-28	Duke University	Oxidoreductase activity of manganic porphyrins
JP2001521939A (en)	1997-11-03	2001-11-13	デューク・ユニバーシティー	Substituted porphyrins
ATE311206T1 (en)	1998-04-24	2005-12-15	Univ Duke	SUBSTITUTED PORPHYRINS
US6632808B1 (en)	1998-08-11	2003-10-14	The United States Of America As Represented By The Department Of Health And Human Services	Inhibitors of amyloid formation
IL126953A0 (en) *	1998-11-08	1999-09-22	Yeda Res & Dev	Pharmaceutical compositions comprising porphyrins and some novel porphyrin derivatives
EP1013272A1 (en) *	1998-12-23	2000-06-28	Biomedical Primate Research Centre (BPRC)	Manipulation of the activity of a nitric oxide radical production pathway for the treatment of diseases associated with the presence of oxygen free radicals
NZ513164A (en)	1999-01-25	2006-03-31	Nat Jewish Med & Res Center	Substituted porphyrins
US6448239B1 (en)	1999-06-03	2002-09-10	Trustees Of Princeton University	Peroxynitrite decomposition catalysts and methods of use thereof
FR2806911B1 (en) *	2000-03-28	2003-01-10	Univ Rene Descartes	USE OF SOD MIMETICS IN THE TREATMENT OF HEPATOCELLULAR DEFICIENCIES
EP1392328B1 (en) *	2001-01-19	2009-08-12	National Jewish Medical and Research Center	Medicament for protection in radiotherapy
WO2002098431A1 (en)	2001-06-01	2002-12-12	National Jewish Medical And Research Center	Oxidant scavengers for treatment of diabetes or use in transplantation or induction of immune tolerance
WO2003103680A1 (en)	2002-06-07	2003-12-18	Duke University	Substituted porphyrins
DE10240343A1 (en) *	2002-08-27	2004-03-11	Schering Ag	Peroxynitrite rearrangement catalysts
US6946466B2 (en) *	2003-04-10	2005-09-20	Schering Ag	Aromatic sulfonamides as peroxynitrite-rearrangement catalysts
US8165651B2 (en)	2004-02-09	2012-04-24	Abbott Diabetes Care Inc.	Analyte sensor, and associated system and method employing a catalytic agent
US7699964B2 (en)	2004-02-09	2010-04-20	Abbott Diabetes Care Inc.	Membrane suitable for use in an analyte sensor, analyte sensor, and associated method
US7705040B2 (en) *	2005-10-07	2010-04-27	The University Of Hong Kong	Reagents for highly specific detection of peroxynitrite
US7885698B2 (en)	2006-02-28	2011-02-08	Abbott Diabetes Care Inc.	Method and system for providing continuous calibration of implantable analyte sensors
WO2008094222A2 (en)	2006-10-06	2008-08-07	Trustees Of Princeton	Porphyrin catalysts and methods of use thereof
EP2192899B1 (en)	2007-08-28	2014-10-01	Technion Research and Development Foundation, Ltd.	Transition metal complexes of corroles for preventing cardiovascular diseases or disorders
ES2600469T3 (en)	2008-05-23	2017-02-09	National Jewish Health	A compound for use in the treatment of lesions associated with exposure to phosgene gas or chlorine gas
EP3089666B1 (en)	2013-12-31	2020-08-19	Abbott Diabetes Care Inc.	Self-powered analyte sensor and devices using the same
RU2557655C1 (en) *	2014-06-10	2015-07-27	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Ивановский государственный химико-технологический университет" (ФГБОУ ВПО "ИГХТУ")	Nickel complex of 5,10,15,20-tetrakis [3',5'-di(2"-methylbutyloxy)phenyl]-porphin, demonstrating property of stationary phase for gas chromatography
CN107573259A (en) *	2017-09-25	2018-01-12	沅江华龙催化科技有限公司	A kind of method of catalysis of metalloporphyrin aromatic olefin synthesis aromatic nitriles
EP4059496A1 (en) *	2021-03-18	2022-09-21	Institut Pasteur	Mntbap and m(iii) n-substituted pyridylporphyrins (mnps) for use in reversing sepsis-induced microglial cells alteration(s), associated long-term cognitive impairment, and/or for treating sepsis or sepsis-associated encephalopathy (sae), and/or related short and/or long-term symptoms or complications thereof

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ATE91625T1 (en) *	1985-04-30	1993-08-15	Nippon Petrochemicals Co Ltd	USE OF PORPHYRIN DERIVATIVES IN THE DETECTION AND TREATMENT OF TUMORS.
ATE87826T1 (en) *	1986-01-02	1993-04-15	Univ Toledo	MANUFACTURE AND USE OF PURPURIN, CHLORIN, AND PREPARATIONS CONTAINING PURPURIN AND CHLORIN.
US4866054A (en) *	1986-05-13	1989-09-12	Chai-Tech Corporation	Antioxidant metallo-organic treatment of inflammation
WO1989002269A1 (en) *	1987-09-08	1989-03-23	The Rockefeller University	Use of metalloporphyrins to reverse the toxic effect of tumor therapy
ATE146508T1 (en) *	1990-11-02	1997-01-15	Zeneca Ltd	POLYSUBSTITUTED PHTHALOCYANINES
CA2096333A1 (en) *	1990-11-14	1992-05-15	Joseph S. Beckman	Compositions for reducing oxidative injury
FR2676738B1 (en) *	1991-05-22	1995-05-05	Ir2M	NOVEL ORGANIC TRANSITION METAL WITH PORPHYRINIC STRUCTURE, THERAPEUTIC COMPOSITION CONTAINING SAME, IN PARTICULAR WITH HYPOGLYCEMIC ACTIVITY.
GB9111689D0 (en) *	1991-05-31	1991-07-24	Johnson Matthey Plc	Gallium compounds
EP0598753B1 (en) *	1991-07-19	1998-03-18	Monsanto Company	Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
CA2124204A1 (en) *	1991-11-25	1993-06-10	H. Dewayne Ashmead	Composition and method for reducing free radical cellular oxidative stress in warm-blooded animals
US5296466A (en) *	1992-02-19	1994-03-22	Board Of Regents, The University Of Texas System	Inhibition of nitric oxide-mediated hypotension and septic shock with iron-containing hemoprotein
US5403834A (en) *	1992-12-07	1995-04-04	Eukarion, Inc.	Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease
US6204259B1 (en) *	1993-01-14	2001-03-20	Monsanto Company	Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide
GB9309387D0 (en) *	1993-05-06	1993-06-16	Wellcome Found	Nitric oxide scavengers
GB9317686D0 (en) *	1993-08-25	1993-10-13	Johnson Matthey Plc	Pharmaceutical compositions

1995
- 1995-05-09 CZ CZ963234A patent/CZ323496A3/en unknown
- 1995-05-09 WO PCT/US1995/005886 patent/WO1995031197A1/en not_active Ceased
- 1995-05-09 CN CNB951940759A patent/CN1222286C/en not_active Expired - Fee Related
- 1995-05-09 PL PL95317192A patent/PL317192A1/en unknown
- 1995-05-09 CA CA002189528A patent/CA2189528A1/en not_active Abandoned
- 1995-05-09 JP JP7529755A patent/JPH10500671A/en not_active Ceased
- 1995-05-09 NZ NZ285648A patent/NZ285648A/en unknown
- 1995-05-09 EP EP95919143A patent/EP0758892A1/en not_active Withdrawn
- 1995-05-09 BR BR9507643A patent/BR9507643A/en not_active Application Discontinuation
- 1995-05-09 HU HU9603140A patent/HUT76327A/en not_active Application Discontinuation
- 1995-05-09 AU AU25120/95A patent/AU709553B2/en not_active Ceased
1996
- 1996-11-12 NO NO964793A patent/NO964793L/en not_active Application Discontinuation
- 1996-11-12 FI FI964537A patent/FI964537A7/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
HU9603140D0 (en)	1997-01-28
AU709553B2 (en)	1999-09-02
CZ323496A3 (en)	1997-10-15
FI964537A7 (en)	1997-01-10
AU2512095A (en)	1995-12-05
NO964793L (en)	1997-01-06
NZ285648A (en)	1999-08-30
HUT76327A (en)	1997-08-28
CA2189528A1 (en)	1995-11-23
NO964793D0 (en)	1996-11-12
CN1152871A (en)	1997-06-25
PL317192A1 (en)	1997-03-17
EP0758892A1 (en)	1997-02-26
WO1995031197A1 (en)	1995-11-23
FI964537A0 (en)	1996-11-12
JPH10500671A (en)	1998-01-20
CN1222286C (en)	2005-10-12

Publication	Publication Date	Title
BR9507643A (en)	1997-09-23	Methods of use for peroxynitrite decomposition catalysts pharmaceutical compositions for them
BR9501770A (en)	1995-11-21	Use of a compound, compound, pharmaceutical formulation and process for preparing a compound
BR9602705A (en)	1998-09-08	Compound pharmaceutical composition process for the preparation of a compound and use
BR1100323A (en)	2000-06-27	Compound, use of a compound, pharmaceutical composition and process for preparing a compound
MX9100317A (en)	1992-02-28	NEW BETA-LACTAMA COMPOUNDS, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
PT998272E (en)	2003-09-30	PHARMACEUTICAL COMPOSITION FOR COMBINATION OF PIPERIDINOALCANOL DECONGESTIONANT
AR008586A1 (en)	2000-02-09	ARYL DERIVATIVE COMPOUND ALKYLAMINE ALPHA, ALPHA-DISSTITUTED, PHARMACEUTICAL COMPOSITION CONTAINING IT, METHOD FOR THE DETERMINATION OF THE CALCILITIC ACTIVITY OF A COMPOUND AND USE OF SUCH COMPOUNDS FOR THE MANUFACTURE OF A MEDICINAL PRODUCT
BR9000038A (en)	1990-10-09	DISTRIBUTOR FOR RELEASE OF VISCOUS SUBSTANCES
BR9708014A (en)	1999-07-27	Arylglycinamide derivatives process for the preparation of them and pharmaceutical compositions containing these compounds
BR9505107A (en)	1997-09-09	Compound pharmaceutical composition process for the preparation of a compound and its use
BR9602150A (en)	1998-06-30	Process compounds for its preparation process for the production of a pharmaceutical formulation pharmaceutical formulation and use
MX7668A (en)	1993-08-01	NEW PHARMACEUTICAL COMPOUNDS AND PROCEDURE FOR OBTAINING THEM
BR9711008A (en)	1999-08-17	Multiline derivatives of carbamoyl azabicycles for antibacterial use
BR9600339A (en)	1998-01-27	Compounds pharmaceutical compositions process for the preparation of a compound and use thereof
MX14533A (en)	1993-10-01	PROCEDURE FOR THE PREPARATION OF PHARMACEUTICAL COMPOUNDS
BR9602025A (en)	1998-10-06	Compound use, pharmaceutical composition and process for the preparation of a compound
BR9800718A (en)	1999-06-29	Steroid compound pharmaceutical composition use of a steroid compound and process for the preparation of a steroid
BR9606596A (en)	1997-10-28	Compound process for preparing a compound cosmetic or pharmaceutical composition and use of a compound
MX9102499A (en)	1992-06-01	DERIVATIVES OF BENZAMIDE, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
MX9100630A (en)	1992-04-01	USE OF MOLYBDENO COMPOUNDS FOR PAINT COAGULATION
MX9101594A (en)	1992-07-08	INDENOIDOL COMPOUNDS, PROCEDURE FOR THE PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING THEM
BR9703403A (en)	1998-09-15	Process compounds for compound preparation use of compound and process for pharmaceutical composition preparation
MX174317B (en)	1994-05-04	PROCEDURE FOR THE PREPARATION OF 1-HYDROXIMETILPIRAZOLES
FI953720A0 (en)	1995-08-04	Use of neurotensin antagonists for the preparation of diuretic drugs
MX9101794A (en)	1992-06-05	TRIFENDIOXAZINE COMPOUNDS AND PROCEDURE FOR THE PREPARATION

Legal Events

Date	Code	Title
2004-04-13	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2004-09-14	B07A	Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
2005-03-01	B09B	Patent application refused [chapter 9.2 patent gazette]
2005-06-07	B12B	Appeal against refusal [chapter 12.2 patent gazette]